Syndax Pharmaceuticals Inc
$ 20.53
3.17%
24 Feb - close price
- Market Cap 1,729,605,000 USD
- Current Price $ 20.53
- High / Low $ 20.64 / 19.78
- Stock P/E N/A
- Book Value 1.33
- EPS -3.60
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.39 %
- ROE -1.29 %
- 52 Week High 22.73
- 52 Week Low 8.58
About
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts.
Analyst Target Price
$38.92
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-03 | 2025-08-04 | 2025-05-06 | 2025-02-25 | 2024-11-05 | 2024-08-01 | 2024-05-08 | 2024-02-27 | 2023-11-02 | 2023-08-03 | 2023-05-08 | 2023-02-28 |
| Reported EPS | -0.7 | -0.83 | -0.9846 | -1.1 | -0.98 | -0.8 | -0.85 | -1 | -0.73 | -0.64 | -0.59 | -0.62 |
| Estimated EPS | -0.73 | -1.01 | -1.2734 | -0.2289 | -1.11 | -0.91 | -0.98 | -0.99 | -0.8 | -0.73 | -0.6 | -0.65 |
| Surprise | 0.03 | 0.18 | 0.2888 | -0.8711 | 0.13 | 0.11 | 0.13 | -0.01 | 0.07 | 0.09 | 0.01 | 0.03 |
| Surprise Percentage | 4.1096% | 17.8218% | 22.6794% | -380.5592% | 11.7117% | 12.0879% | 13.2653% | -1.0101% | 8.75% | 12.3288% | 1.6667% | 4.6154% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.64 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
